Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer?
Introduction
Primary therapy of patients with cervical cancer is done surgically or by chemoradiation. Patients with early tumor stage such as IA2 to IIB are mainly treated surgically, whereas patients diagnosed with stage IB2 or higher undergo primary chemoradiation [1], [9], [10], [17], [29], [30], [40]. The clinical staging according to FIGO is based on the quality of the clinical examination and forms the basis for the decision to recommend surgery or chemoradiation. Comparison of surgery versus radiation in patients with FIGO stage IB to IIA shows no survival benefit in either arm, but increased morbidity when adjuvant radiotherapy has to be given after surgery [26].
According to the FIGO guidelines, cervical cancer continues to be the only gynecologic malignancy that is at present not surgically staged. This implicates a considerable rate of over- and understaging [40], [51]. Imaging techniques such as CT, MRI, or PET show high accuracy for evaluating tumor size, involvement of parametrium or vagina, and lymph node enlargement. However, the detection of tumor-involvement in regular sized lymph nodes, and of tumor foci in edematous tissue is difficult [2], [13], [14], [15], [18], [19], [31], [41], [44]. Thus, imaging techniques cannot fill the diagnostic gap between clinical and surgical–histological staging. On the other hand, detection of metastases in pelvic and/or paraaortic lymph nodes is the most important prognostic factor for the survival in patients with cervical cancer [3], [25], [28], [31], [35], [45], [47], [51]. Exact evaluation of tumor spread intraabdominally, in lymph nodes and/or adjacent organs can only be done by surgical and histophathologic evaluation [3], [7], [8], [12], [13], [24], [32], [38], [48]. However, operative staging by laparotomy is associated with increased bowel morbidity during subsequent radiation and delayed beginning of radiation, reasons which have led in the past to an extraperitoneal approach [6], [12], [38], [43], [49]. Following the introduction of laparoscopic pelvic and paraaortic lymphadenectomy, minimal invasive staging of patients with cervical cancer can be done without increasing morbidity [3], [4], [21], [22], [36], [38], [43], [48]. However, a recent prospective study showed a survival disadvantage for patients following surgical (open or laparoscopic) staging compared to clinical staging when primary chemoradiation was performed [24].
Sentinel concept may be useful in the future for detection and exstirpation of relevant lymph nodes, but is still under research [34]. The value of debulking of tumor-involved lymph nodes in patients with cervical cancer is also controversially discussed [11], [20], [23], [27], [37], [46]. Since multimodal therapy and improvement of the technique of brachytherapy allow successful treatment of the loco-regional disease, techniques which allow treatment of lymph node metastases become increasingly important [9], [10], [25], [27]. It was the purpose of this study to evaluate the results of primary laparoscopic transperitoneal staging including debulking of lymph nodes in patients with primary cervical cancer and to analyze the oncologic outcome following subsequent primary chemoradiation.
Section snippets
Material and methods
Between November 1994 and October 2003, 456 women with histological confirmed primary cervical cancer of all FIGO-stages were treated at the Department of Gynecology of the Friedrich–Schiller-University in Jena, Germany. Following preoperative counseling, all patients were staged laparoscopically. According to the findings of surgical and subsequent histopathological staging, treatment was either completed surgically (by a one or two step procedure) and/or by chemoradiation.
On the basis of
Results
Mean age of patients was 54 years (27–80), and the mean body-mass-index 24.8 (17.9–42.4). Preoperative evaluation according to FIGO resulted in stage IB1 in 13 (15.5%), IB2 in 13 (15.5%), IIA in 7 (8.3%), IIB in 20 (23.8%), IIIA in 7 (8.3%), IIIB in 18 (21.4%), IVA in 5 (6%), and IVB in 1 (1.2%) out of 84 patients (Table 2). Histology revealed squamous cancer in 74 patients, adenocarcinoma in 7 patients, and adenosquamous cancer in 3 patients. Grading was confirmed as G1 in 4, G2 in 44, G3 in
Discussion
“Disparage pretreatment laparoscopic surgical staging, since there is no more justification for it than for the now abandoned pretreatment laparotomy and staging” [42]. This hypothesis was postulated by Shingelton in 1998, a period where more than 29 applications were available on the topic of surgical staging in patients with cervical cancer. Additional 13 studies have been published since then, which encompassed the analysis of 4264 patients.
It is well known, that women with locally advanced
References (51)
- et al.
Laparoscopic surgical staging in cervical cancer-preliminary experience among Chinese
Gynecol. Oncol.
(1997) - et al.
Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer
Gynecol. Oncol.
(2005) - et al.
Pretreatment surgical staging in cervical carcinoma: therapeutic efficacy of pelvic lymph node resection
Am. J. Obstet. Gynecol.
(1989) - et al.
Impact of surgical staging in women with locally advanced cervical cancer
Gynecol. Oncol.
(1999) - et al.
Survival and recurrences after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis
Lancet
(2001) - et al.
Evaluation of patients after extraperitoneal lymph node dissection and subsequent radiotherapy for cervical cancer
Gynecol. Oncol.
(2002) - et al.
Laparoscopic staging compared with imaging techniques in the staging of advanced cervical cancer
Gynecol. Oncol.
(2002) - et al.
Surgical–pathological predictors of disease-free survival and risk grouping for IB2 cervical cancer: do the traditional models still apply?
Gynecol. Oncol.
(2004) - et al.
Cervical cancer with paraaortic metastases: significance of residual paraaortic disease after surgical staging
Gynecol. Oncol.
(1998) - et al.
Laparoscopic paraaortic left-sided transperitoneal infrarenal lymphadenectomy in patients with gynecologic malignancies: technique and results
Gynecol. Oncol.
(2003)
Introduction of transperitoneal lymphadenectomy in a gynecologic oncology center: analysis of 650 laparoscopic and/or paraaortic transperitoneal lymphadenectomies
Gynecol. Oncol.
Randomized trial of surgical (extraperitoneal or laparoscopic) versus clinical staging in locally advanced cervical cancer
Gynecol. Oncol.
Tumor and treatment factors improving outcome in stage III-B cervix cancer
Int. J. Radiat. Oncol. Biol. Phys.
Randomised study of radical surgery versus radiotherapy for stage Ib–IIa cervical cancer
Lancet
Paraaortic lymph node metastasis as a sole site of failure from cervix cancer: curable or incurable disease?
Int. J. Radiat. Oncol. Biol. Phys.
Lymphatic spread in stage Ib and II cervical carcinoma: anatomy and surgical implications
Obstet. Gynecol.
Laparoscopic sentinel node mapping in early-stage cervical cancer
Gynecol. Oncol.
Extended field irradiation in the treatment of patients with cervical carcinoma involving biopsy proven para-aortic nodes
Int. J. Radiat. Oncol. Biol. Phys.
Laparoscopic para-aortic and pelvic lymphadenectomy: experience with 150 patients and review of the literature
Gynecol. Oncol.
The role of surgical debulking in cancer of the uterine cervix
Int. J. Radiat. Oncol. Biol. Phys.
Prospective evaluation of surgical staging of advanced cervical cancer via a laparoscopic extraperitoneal approach
Gynecol. Oncol.
Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging
Obstet. Gynecol.
Survival following extended field irradiation in carcinoma of cervix metastatic to para-aortic lymph nodes
Gynecol. Oncol.
Extraperitoneal versus transperitoneal selective paraaortic lymphadenectomy in the pretreatment surgical staging of advanced cervical carcinoma (a Gynecologic Oncology Group study)
Gynecol. Oncol.
The abandoned radical hysterectomy: a Gynecologic Oncology Group study
Gynecol. Oncol.
Cited by (165)
The impact of para-aortic lymph node irradiation on disease-free survival in patients with cervical cancer: A systematic review and meta-analysis
2022, Clinical and Translational Radiation OncologyInterest of para-aortic lymphadenectomy for locally advanced cervical cancer in the era of PET scanning
2022, European Journal of Obstetrics and Gynecology and Reproductive BiologyLaparoscopic Debulking of Enlarged Pelvic Nodes during Surgical Para-aortic Staging in Locally Advanced Cervical Cancer: A Retrospective Comparative Cohort Study
2022, Journal of Minimally Invasive GynecologyTransperitoneal versus extraperitoneal laparoscopic aortic lymph nodal staging for locally advanced cervical cancer: A systematic review and meta-analysis
2021, European Journal of Surgical Oncology